0001209191-21-021528.txt : 20210317
0001209191-21-021528.hdr.sgml : 20210317
20210317183626
ACCESSION NUMBER: 0001209191-21-021528
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210315
FILED AS OF DATE: 20210317
DATE AS OF CHANGE: 20210317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EVANS GARY C
CENTRAL INDEX KEY: 0001191410
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 21752179
MAIL ADDRESS:
STREET 1: 1048 TEXAN TRAIL
CITY: GRAPEVINE
STATE: TX
ZIP: 76051
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 21 FIRSTFIELD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-03-15
0
0001000694
NOVAVAX INC
NVAX
0001191410
EVANS GARY C
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG
MD
20878
1
0
0
0
Common Stock
2021-03-15
4
M
0
2000
99.80
A
18099
D
Common Stock
2021-03-15
4
M
0
4500
46.00
A
22599
D
Common Stock
2021-03-15
4
M
0
18000
3.985
A
40599
D
Common Stock
2021-03-15
4
S
0
9732
210.00
D
30867
D
Common Stock
2021-03-15
4
S
0
14768
212.00
D
16099
D
Common Stock
625
I
By Evans 1997 Trust
Stock Option (Right to Buy)
99.80
2021-03-15
4
M
0
2000
0.00
D
2016-09-15
2026-03-15
Common Stock
2000
0
D
Stock Option (Right to Buy)
46.00
2021-03-15
4
M
0
4500
0.00
D
2019-12-13
2028-12-13
Common Stock
4500
0
D
Stock Option (Right to Buy)
3.985
2021-03-15
4
M
0
18000
0.00
D
2020-12-12
2029-12-12
Common Stock
18000
0
D
The reporting person indirectly beneficially owns 625 shares held by the Evans 1997 Trust.
One hundred percent (100%) of the shares subject to this option grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan") vested six (6) months from the March 15, 2016 grant date.
One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 13, 2018 grant date.
One hundred percent (100%) of the shares subject to this option grant under the Plan vested one (1) year from the December 12, 2019 grant date.
/s/ John A. Herrmann III, Attorney-in-Fact
2021-03-17